selected publications
-
Genome doubling shapes the evolution and prognosis of advanced cancers.
Nature genetics.
2018
Academic Article
GET IT
Times cited: 468 -
KMT2C mediates the estrogen dependence of breast cancer through regulation of ERĪ± enhancer function.
Oncogene.
2018
Academic Article
GET IT
Times cited: 112 -
Erratum: Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.
2017
GET IT
Times cited: 23 -
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.
Nature medicine.
2017
Academic Article
GET IT
Times cited: 2762 -
Capturing Genomic Evolution of Lung Cancers through Liquid Biopsy for Circulating Tumor DNA.
Journal of oncology.
2017
Review
GET IT
Times cited: 23 -
A phase 1b dose expansion study of the pan-class I PI3K inhibitor buparlisib (BKM120) plus carboplatin and paclitaxel in PTEN deficient tumors and with dose intensified carboplatin and paclitaxel.
Investigational new drugs.
2017
Academic Article
GET IT
Times cited: 14 -
Next-Generation Assessment of Human Epidermal Growth Factor Receptor 2 (ERBB2) Amplification Status: Clinical Validation in the Context of a Hybrid Capture-Based, Comprehensive Solid Tumor Genomic Profiling Assay.
The Journal of molecular diagnostics : JMD.
2016
Academic Article
GET IT
Times cited: 123 -
Systematic Functional Characterization of Resistance to PI3K Inhibition in Breast Cancer.
Cancer discovery.
2016
Academic Article
GET IT
Times cited: 116 -
Variable risk of second primary malignancy in multiple myeloma patients of different ethnic subgroups.
Blood cancer journal.
2014
Academic Article
GET IT
Times cited: 22